Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Weight management

Recent news which mentions Weight management

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Pharmaceuticals Health & Science Weight management
From CNBC.com News
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Tags Health care industry Technology Hospitals
From CNBC.com News
If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
Tags Make It / Save and Invest Make It / Money Weight management
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Science Finance Biotechnology
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Health & Science Weight management Eli Lilly and Co
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Cigna Corp Breaking news Companies
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Diet and exercise Health care industry Health
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Zoetis Inc Pharmaceutical industry regulation Weight management
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Weight management Pharmaceuticals Health & Science
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags AstraZeneca PLC Pharmaceuticals Health & Science
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Altimmune Inc Business News Biotechnology
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Health care industry Business Companies
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Business Breaking News: Earnings Health care industry
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Enterprise Breaking News: Technology Technology
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Stock markets Weight loss diets Weight management
From CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Business Health care industry Brand acquisitions
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
Tags Business News Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Tags Health care industry Business Breaking news
From CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
Tags Politics Weight management Pharmaceuticals
From CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Tags Retail Pharmaceuticals Health & Science
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Tags Health care industry Heart attack Business
From CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Tags Companies Breaking news Business
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Tags Health & Science Pharmaceuticals Social issues
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
Tags Biotechnology Biotech and Pharmaceuticals Science
From CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Tags Biotechnology Biotech and Pharmaceuticals Suicides
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Biotech and Pharmaceuticals Biotechnology Business News
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags Science Business News Suicides
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Insurance industry Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Weight management Pharmaceuticals Health & Science
From CNBC.com News
TikTokers say berberine is 'nature's Ozempic': Here's what doctors want you to know about the buzzy supplement
Tags Health Tips and Wellness Advice Make It / Life Make It
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.